Future cancer research priorities in the USA: a Lancet Oncology Commission

EM Jaffee, C Van Dang, DB Agus… - The Lancet …, 2017 - thelancet.com
We are in the midst of a technological revolution that is providing new insights into human
biology and cancer. In this era of big data, we are amassing large amounts of information …

Targeted radionuclide therapy: an evolution toward precision cancer treatment

H Jadvar - American Journal of Roentgenology, 2017 - Am Roentgen Ray Soc
OBJECTIVE. This article reviews recent developments in targeted radionuclide therapy
(TRT) approaches directed to malignant liver lesions, bone metastases, neuroendocrine …

Targeted radionuclide therapy: practical applications and future prospects: supplementary issue: biomarkers and their essential role in the development of …

K Zukotynski, H Jadvar, J Capala… - Biomarkers in …, 2016 - journals.sagepub.com
In recent years, there has been a proliferation in the development of targeted radionuclide
cancer therapy. It is now possible to use baseline clinical and imaging assessments to …

Bone-targeted imaging and radionuclide therapy in prostate cancer

AH Iagaru, E Mittra, PM Colletti… - Journal of Nuclear …, 2016 - Soc Nuclear Med
Although selective metabolic and receptor-based molecular agents will surely be included in
the future of prostate cancer diagnosis and therapy, currently available inorganic …

National Cancer Institute support for targeted alpha-emitter therapy

JA Hong, M Brechbiel, J Buchsbaum… - European Journal of …, 2021 - Springer
Background Radiopharmaceutical targeted therapy (RPT) has been studied for decades;
however, recent clinical trials demonstrating efficacy have helped renewed interest in the …

Targeted radionuclide therapy: frontiers in theranostics

F Gallivanone, MA Valente, A Savi, C Canevari… - 2017 - ri.conicet.gov.ar
The concept of targeted radionuclide therapy (TRT) relies on the use of injected nuclear
medicine as treating agents, targeted at the cellular or molecular level. The growth of the …

Advancing targeted radionuclide therapy through the national cancer institute's small business innovation research pathway

K Zakeri, D Narayanan, G Evans… - Journal of Nuclear …, 2019 - Soc Nuclear Med
The Small Business Innovation Research (SBIR) and Small Business Technology Transfer
(STTR) programs of the National Cancer Institute (NCI) are congressionally mandated set …

[BOOK][B] Bone health and bone-targeted therapies for prostate cancer

S Alibhai, K Zukotynski, C Walker-Dilks… - 2016 - cancercareontario.ca
Prostate cancer is the most common internal malignancy in men and the third most common
cause of cancer death. There were an estimated 24,000 new cases and 4100 deaths due to …

Radiation Dosimetry in Ibritumomab Therapy

G Glatting - Resistance to Ibritumomab in Lymphoma, 2018 - Springer
Radioimmunotherapy (RIT) is a special case of targeted radionuclide therapy (TRT) or
molecular radiotherapy (MRT) which uses a monoclonal antibody as transporter of the …

[PDF][PDF] A. Personal information

B Education - 2010 - floridacot.org
2. Large animal evaluation of the safety and efficacy of the systemic administration of
Thrombosome for diffuse, non-surgical hemorrhage, Grant#: 300831, Cellphire, Inc …